These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man. Chopra IJ J Clin Invest; 1976 Jul; 58(1):32-40. PubMed ID: 932209 [TBL] [Abstract][Full Text] [Related]
23. The thyroid-system function in preterm infants of postmenstrual ages of 31 weeks or less: evidence for a "transient lazy thyroid system". Eggermont E; Vanderschueren-Lodeweyckx M; De Nayer P; Smeets E; Vanacker G; Cornette C; Jaeken J; Devlieger H; Eeckels R; Beckers C Helv Paediatr Acta; 1984 Aug; 39(3):209-22. PubMed ID: 6544306 [TBL] [Abstract][Full Text] [Related]
24. [Dopaminergic and somatostatinergic pathways decrease serum thyrotropin in rats bearing the 256-Walker mammary carcinoma]. Monte O; Zyngier S; Kimura ET; Bianco AC Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):253-64. PubMed ID: 16184254 [TBL] [Abstract][Full Text] [Related]
25. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors. Seo H; Refetoff S; Fang VS Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484 [TBL] [Abstract][Full Text] [Related]
26. Differential response to L-triiodothyronine of anterior pituitary growth hormone messenger ribonucleic acid (mRNA) and beta-thyrotropin mRNA in a hypothyroid Walker 256 carcinoma-bearing rat model of nonthyroidal disease. Hupart KH; DeFesi CR; Katz CP; Shapiro LE; Surks MI Endocrinology; 1990 Jan; 126(1):616-21. PubMed ID: 2294008 [TBL] [Abstract][Full Text] [Related]
27. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH". Gershengorn MC; Weintraub BD J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077 [TBL] [Abstract][Full Text] [Related]
28. Effect of Iopanoic acid on the pituitary-thyroid axis: time sequence of changes in serum iodothyronines, thyrotropin, and prolactin concentrations and responses to thyroid hormones. Suzuki H; Noguchi K; Nakahata M; Nakagawa S; Kadena N J Clin Endocrinol Metab; 1981 Oct; 53(4):779-83. PubMed ID: 6793610 [TBL] [Abstract][Full Text] [Related]
29. Thyroid hormone control of thyrotropin gene expression in rat anterior pituitary cells. Shupnik MA; Ridgway EC Endocrinology; 1987 Aug; 121(2):619-24. PubMed ID: 2439318 [TBL] [Abstract][Full Text] [Related]
30. Thyrotropin-releasing hormone and thyroid hormone interactions on thyrotropin secretion in the rat: lack of inhibiting effects of small doses of triiodo-L-thyronine in the hypothyroid rat. García MD; Escobar del Rey F; Morreale de Escobar G Endocrinology; 1976 Jan; 98(1):203-13. PubMed ID: 813987 [TBL] [Abstract][Full Text] [Related]
31. Iodothyronine deiodination in rats with severe non-thyroidal illness. Grussendorf M; Wollensack G; Hüfner M Acta Endocrinol (Copenh); 1988 May; 118(1):31-7. PubMed ID: 3389049 [TBL] [Abstract][Full Text] [Related]
32. Effect of endotoxin on hormonal responses to thyrotropin and thyrotropin-releasing hormone in dogs. Yu AA; Kemppainen RJ; MacDonald JM Am J Vet Res; 1998 Feb; 59(2):186-91. PubMed ID: 9492934 [TBL] [Abstract][Full Text] [Related]
33. Serum levels of thyrotropin, thyroid hormones and their response to thyrotropin releasing hormone in infective febrile illnesses. Talwar KK; Sawhney RC; Rastogi GK J Clin Endocrinol Metab; 1977 Feb; 44(2):398-403. PubMed ID: 402380 [TBL] [Abstract][Full Text] [Related]
34. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases. Maturlo SJ; Rosenbaum RL; Pan C; Surks MI J Clin Invest; 1980 Sep; 66(3):451-6. PubMed ID: 6772675 [TBL] [Abstract][Full Text] [Related]
35. Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only. Lim VS; Passo C; Murata Y; Ferrari E; Nakamura H; Refetoff S Endocrinology; 1984 Jan; 114(1):280-6. PubMed ID: 6317348 [TBL] [Abstract][Full Text] [Related]
36. Effect of interleukin-1 (IL-1) on thyroid hormone metabolism in mice: stimulation by IL-1 of iodothyronine 5'-deiodinating activity (type I) in the liver. Fujii T; Sato K; Ozawa M; Kasono K; Imamura H; Kanaji Y; Tsushima T; Shizume K Endocrinology; 1989 Jan; 124(1):167-74. PubMed ID: 2783307 [TBL] [Abstract][Full Text] [Related]
37. Effect of in vivo administration of recombinant acidic fibroblast growth factor on thyroid function in the rat: induction of colloid goiter. De Vito WJ; Chanoine JP; Alex S; Fang SL; Stone S; Huber CA; Shalhoub V; Lian JB; Stein GS; Braverman LE Endocrinology; 1992 Aug; 131(2):729-35. PubMed ID: 1379163 [TBL] [Abstract][Full Text] [Related]
38. Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the rat. Hermus RM; Sweep CG; van der Meer MJ; Ross HA; Smals AG; Benraad TJ; Kloppenborg PW Endocrinology; 1992 Nov; 131(5):2139-46. PubMed ID: 1425414 [TBL] [Abstract][Full Text] [Related]
39. Diminished hepatic L-triiodothyronine nuclear receptor concentration in rats bearing the Walker 256 carcinoma is not due to a generalized decrease in nonhistone protein synthesis. Starosta Z; Gasparini F; Shapiro LE; Surks MI Endocrinology; 1988 Aug; 123(2):1172-7. PubMed ID: 3396502 [TBL] [Abstract][Full Text] [Related]
40. The mechanism of damping of the serum thyroxine and triidothyronine levels caused by increasing thyrotropin dosage in mice. Gafni M; Saddok C; Sirkis N; Gross J Endocrinology; 1977 Apr; 100(4):1186-91. PubMed ID: 189993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]